Dr. Pollock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10109 E 79th St
Tulsa, OK 74133Phone+1 918-286-5000Fax+1 918-249-7514
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
A. T. Still University Kirksville College of Osteopathic MedicineClass of 1973
Certifications & Licensure
OK State License 2008 - 2025
OH State License 1974 - 2014
WV State License 1974 - 1979
Clinical Trials
- Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 32 citationsCetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Pro...Julie Gottlieb Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat
Targeted Oncology. 2020-10-22 - 7 citationsTesticular metastasis in a case of squamous cell carcinoma of the lung.Dennis Andrew Buck, Robert H. Byrd, Cynthia L. Holmes, Theodore Pollock
Case Reports in Oncology. 2015-03-03 - 5 citationsPhase II trial of trimetrexate in untreated advanced gastric carcinoma. A Southwest Oncology Group study.Alexander Hantel, Catherine M. Tangen, Stephen P. Richman, Reginald P. Pugh, Theodore W. Pollock
Investigational New Drugs. 1994-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
